FLT3 and acute myeloid leukemia: This study presents a novel approach to increase Dox and Cur cytotoxicity in AML cell lines by demonstrating the development and utilization of Dox-Cur micelles conjugated with two FLT3 peptides, which can bind to different sites on the FLT3 receptor in AML LSCs and leukemic cells.